We have performed direct investigations of these antitumoral effects through tumor cell migration and cell cycle analysis on two different EGFR overexpressing cell lines, T24 bladder cancer and HeLa cervical cancer cells using miR200c loaded MSN-454-GE11 samples. This evidence concerns the gene EGFR and urinary bladder carcinoma.